473 related articles for article (PubMed ID: 24198814)
1. Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides.
Mulder KC; Lima LA; Miranda VJ; Dias SC; Franco OL
Front Microbiol; 2013; 4():321. PubMed ID: 24198814
[TBL] [Abstract][Full Text] [Related]
2. Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.
Niyonsaba F; Kiatsurayanon C; Chieosilapatham P; Ogawa H
Exp Dermatol; 2017 Nov; 26(11):989-998. PubMed ID: 28191680
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance.
Nuti R; Goud NS; Saraswati AP; Alvala R; Alvala M
Curr Med Chem; 2017; 24(38):4303-4314. PubMed ID: 28814242
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.
Deslouches B; Di YP
Oncotarget; 2017 Jul; 8(28):46635-46651. PubMed ID: 28422728
[TBL] [Abstract][Full Text] [Related]
5. Bacteriocins: perspective for the development of novel anticancer drugs.
Baindara P; Korpole S; Grover V
Appl Microbiol Biotechnol; 2018 Dec; 102(24):10393-10408. PubMed ID: 30338356
[TBL] [Abstract][Full Text] [Related]
6. Caprine Bactenecins as Promising Tools for Developing New Antimicrobial and Antitumor Drugs.
Kopeikin PM; Zharkova MS; Kolobov AA; Smirnova MP; Sukhareva MS; Umnyakova ES; Kokryakov VN; Orlov DS; Milman BL; Balandin SV; Panteleev PV; Ovchinnikova TV; Komlev AS; Tossi A; Shamova OV
Front Cell Infect Microbiol; 2020; 10():552905. PubMed ID: 33194795
[TBL] [Abstract][Full Text] [Related]
7. Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.
Bastos P; Trindade F; da Costa J; Ferreira R; Vitorino R
Med Res Rev; 2018 Jan; 38(1):101-146. PubMed ID: 28094448
[TBL] [Abstract][Full Text] [Related]
8. Reassessing the Host Defense Peptide Landscape.
Haney EF; Straus SK; Hancock REW
Front Chem; 2019; 7():43. PubMed ID: 30778385
[TBL] [Abstract][Full Text] [Related]
9. Roles of d-Amino Acids on the Bioactivity of Host Defense Peptides.
Li H; Anuwongcharoen N; Malik AA; Prachayasittikul V; Wikberg JE; Nantasenamat C
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27376281
[TBL] [Abstract][Full Text] [Related]
10. Novel cationic antimicrobial peptide GW-H1 induced caspase-dependent apoptosis of hepatocellular carcinoma cell lines.
Chen YL; Li JH; Yu CY; Lin CJ; Chiu PH; Chen PW; Lin CC; Chen WJ
Peptides; 2012 Aug; 36(2):257-65. PubMed ID: 22659412
[TBL] [Abstract][Full Text] [Related]
11. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.
Rothan HA; Mohamed Z; Suhaeb AM; Rahman NA; Yusof R
OMICS; 2013 Nov; 17(11):560-7. PubMed ID: 24044366
[TBL] [Abstract][Full Text] [Related]
12. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
[TBL] [Abstract][Full Text] [Related]
13. Bacterial resistance to antimicrobial peptides.
Abdi M; Mirkalantari S; Amirmozafari N
J Pept Sci; 2019 Nov; 25(11):e3210. PubMed ID: 31637796
[TBL] [Abstract][Full Text] [Related]
14. Cationic host defence peptides: potential as antiviral therapeutics.
Gwyer Findlay E; Currie SM; Davidson DJ
BioDrugs; 2013 Oct; 27(5):479-93. PubMed ID: 23649937
[TBL] [Abstract][Full Text] [Related]
15. Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.
Mai S; Mauger MT; Niu LN; Barnes JB; Kao S; Bergeron BE; Ling JQ; Tay FR
Acta Biomater; 2017 Feb; 49():16-35. PubMed ID: 27845274
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic approaches using host defence peptides to tackle herpes virus infections.
Jenssen H
Viruses; 2009 Dec; 1(3):939-64. PubMed ID: 21994576
[TBL] [Abstract][Full Text] [Related]
17. Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.
Zeng Z; Zhang R; Hong W; Cheng Y; Wang H; Lang Y; Ji Z; Wu Y; Li W; Xie Y; Cao Z
Theranostics; 2018; 8(1):199-211. PubMed ID: 29290802
[No Abstract] [Full Text] [Related]
18. Defense peptides: recent developments.
Cytryńska M; Zdybicka-Barabas A
Biomol Concepts; 2015 Aug; 6(4):237-51. PubMed ID: 26203603
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.
Wiradharma N; Khoe U; Hauser CA; Seow SV; Zhang S; Yang YY
Biomaterials; 2011 Mar; 32(8):2204-12. PubMed ID: 21168911
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp.
Chou HT; Kuo TY; Chiang JC; Pei MJ; Yang WT; Yu HC; Lin SB; Chen WJ
Int J Antimicrob Agents; 2008 Aug; 32(2):130-8. PubMed ID: 18586467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
